Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02616796 · ClinicalTrials.gov registry record · Phase 1
Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 71
- Enrollment target
NCT02616796: Completed Phase 1 study, sponsored by Stanford University.
NCT02616796 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02616796, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 71 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate a 2-3 day treatment probe targeted to improving social gaze behavior in children with fragile X syndrome (FXS). The investigators will use the principles of Applied Behavior Analysis (ABA) to shape appropriate social skills. Importantly, the investigators propose to examine the effects of this treatment probe on brain and behavior.
Interventions
- BEHAVIORAL Social gaze training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2015-04 |
| Est. Completion | 2020-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02616796
The ClinicalTrials.gov registry entry for NCT02616796 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Social gaze training is the first listed.
NCT02616796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02616796 about?
NCT02616796 is a clinical study titled "Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome". The purpose of the study is to evaluate a 2-3 day treatment probe targeted to improving social gaze behavior in children with fragile X syndrome (FXS). The investigators will use the principles of Applied Behavior Analysis (ABA) to shape appropriate social skills. Importantly, the investigators prop...
What is the current status of trial NCT02616796?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 71 participants. The study started on 2015-04. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02616796?
The interventions under investigation include: Social gaze training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02616796?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.